Their research led to the development of a drug that nearly doubles the life expectancy for adult cystic fibrosis patients.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Senior Vice President Paul Negulescu has been named ...

The freshly linked pair is chasing new drugs to treat undisclosed autoimmune diseases and also to improve conditioning regimens for sickle cell disease and beta thalassemia. More gentle conditioning ...

Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 11:30 AM EDT Reshma Kewalramani - CEO, President & Director Duncan J.

The landscape of machine learning engineering has evolved dramatically over the past decade, with organizations increasingly demanding scalable, production-ready solutions that deliver measurable ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Senior Vice President Paul Negulescu has been named as one of the winners of this year's Lasker~DeBakey Clinical Medical Researc ...

In today's Morning Rounds newsletter, NIH is finally spending down its coffers, FDA eyes tighter regulations on chatbots for ...

The agency says it’s open to offering speedy approval pathways for new pain medications that can fight the ongoing opioid ...

As of late August 2025, the U.S. stock market is experiencing a slight pullback from record highs, with major indices like the S&P 500 and Dow Jones Industrial Average showing minor declines after a ...